Cover Image

Oversight of the new drug review process and FDA's regulation of Merital : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, second session, May 22, 1986.

Bibliographic Details
Corporate Authors:	United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee, ProQuest (Firm)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. G.P.O., 1987.
Series:	U.S. Congressional Hearings.
Subjects:	United States. > Food and Drug Administration. Drugs > Law and legislation > United States. Drugs > United States > Testing. Nomifensine. Electronic books.
Online Access:	Connect to the full text of this electronic book

Similar Items

FDA and the drug development process : how the agency ensures that drugs are safe and effective.
Published: (2002)

FDA drug approval : review time has decreased in recent years : report to congressional requesters.
Published: (1995)

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [as printed] meets standards for safety and efficacy, March 1, 2005.
Published: (2005)

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [as printed] meets standards for safety and efficacy, March 1, 2005.
Published: (2005)

FDA-approved bargain drugs : generic products must meet high standards.
Published: (2003)

FDA's regulation of the new drug Versed : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, May 5 and 10, 1988.
Published: (1988)

FDA's review process for new drug applications : a management review.
Published: (2003)

FDA review times : statement of Mary R. Hamilton, Director of Program Evaluation in Human Services Areas, Program Evaluation and Methodology Division, before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives.
by: Hamilton, Mary R. (Mary Ruth), 1944-
Published: (1996)

FDA's Regulation of the New Drug Merital.
Published: (1987)

FDA's regulation of the drug "Triazure" : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-fourth Congress, second session, October 27, 1976.
Published: (1976)

FDA's drug and device review process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 6, 1992.
Published: (1992)

Council on Competitiveness and FDA plans to alter the drug approval process at FDA : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, March 19, 1992.
Published: (1993)

Challenges for the FDA : the future of drug safety : workshop summary /
Published: (2007)

The FDA Commission : the delegation of authority to state and local authorities.
Published: (1989)

The FDA Commission : the delegation of authority to state and local authorities.
Published: (1986)

The adequacy of FDA to assure the safety of the nation's drug supply : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, February 13, March 22, 2007.
Published: (2007)

The adequacy of FDA to assure the safety of the nation's drug supply : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, February 13, March 22, 2007.
Published: (2007)

FDA regulation of over-the-counter (OTC) drugs : overview and issues for Congress /
by: Bodie, Agata
Published: (2021)

FDA almanac.

FDA's regulation of the new drug Suprol : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, first session, May 27, 1987.
Published: (1988)

Drugs and biologics : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995-a consumer's perspective, June 19, 1995-FDA review process.
Published: (1995)

FDA policy on home drug testing kits : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, February 6, 1997.
Published: (1997)

FDA drug bulletin.
Published: (1971)

FDA's drug review process and the package label : strategies for writing successful FDA submissions /
by: Brody, Tom
Published: (2017)

FDA regulation of the new drug "Serc" : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, second session /
Published: (1972)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

Las drogas baratas aprobadas por la FDA : los productos genéricos deben satisfacer altos niveles.
Published: (2004)

"Man-in-the-plant", FDA's failure to regulate deceptive drug labeling : hearings before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session, September 8 and 12, 1978.
Published: (1978)

Prescription drugs : FDA guidance and regulations related to data on elderly persons in clinical drug trials.
by: Crosse, Marcia
Published: (2007)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

Drug regulation reform--oversight : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session ...
Published: (1980)

FDA's authority to ensure that drugs prescribed to children are safe and effective /
by: Thaul, Susan
Published: (2019)

Modernizing FDA's regulation of over-the-counter drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. September 13, 2017.
Published: (2018)

Prescription Drugs : FDA's Oversight of the Promotion of Drugs for Off-Label Uses.
Published: (2008)

Review Panel on New Drug Regulation : final report.
Published: (1977)

FDA's regulation of Zomax : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, first session, April 26 and 27, 1983.
Published: (1983)

El proceso del desarrollo de las drogas y la FDA : cómo la agencia asegura que las drogas sean seguras y efectivas.
Published: (2002)

The FDA prescription drug file.
Published: (1991)

FDA's regulation of the marketing of unapproved new drugs : the case of E-Ferol vitamin E aqueous solution : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, second session, May 4, 1984.
Published: (1984)